Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Tumor maligno bronchopulmonar")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 549

  • Page / 22
Export

Selection :

  • and

Abstracts of the 9th Central European Lung Cancer Conference, Gdańsk, Poland, September 23-25, 2004Lung cancer. 2004, Vol 45, issn 0169-5002, 96 p., SUP3Conference Proceedings

Les facteurs de croissance dans la prise en charge thérapeutique des cancers bronchiques = Growth factors in lung cancer managementPONZIO-PRION, Anne.La Lettre du pneumologue. 2004, Vol 7, Num 4, pp II-IV, issn 1292-5977, SUPArticle

Abstracts of the 3rd International Chicago Symposium on Malignancies of the Chest and Head & Neck, Chicago, Illinois, USA, October 7-9, 2004Lung cancer. 2004, Vol 46, issn 0169-5002, 93 p., SUP1Conference Proceedings

Workshop on the management of locally advanced non-small cell lung cancer, October 24-25, 2002, Taipei, TaiwanPERNG, Reury-Perng.Lung cancer. 2003, Vol 42, issn 0169-5002, 60 p., SUP2Conference Proceedings

Clinical end points for the assessment of cytostatic agentsRINALDI, M.Lung cancer. 2002, Vol 38, issn 0169-5002, p. S37, SUP1Conference Paper

Remediastinoscopy: comments and updated resultsLung cancer. 2003, Vol 42, Num 3, pp 363-364, issn 0169-5002, 2 p.Article

Critical factors for patient managementNINANE, V; LE PECHOUX, C; SCULIER, J. P et al.Lung cancer. 2003, Vol 42, pp S7-S8, issn 0169-5002, SUP1Conference Paper

New cytotoxicsCRINO, L.Lung cancer. 2002, Vol 38, pp S41-S42, issn 0169-5002, SUP1Conference Paper

Contributions of the conference Trends in diagnosis and therapy of lung cancer, 13-14 February 2004, Münster, GermanyBERDEL, W. E; BAUMANN, M; DIENEMANN, H et al.Lung cancer. 2004, Vol 45, issn 0169-5002, 271 p., SUP2Conference Proceedings

Substaging of stage I: a commentaryWATANABE, Yoh.Lung cancer. 2003, Vol 42, Num 1, pp 59-61, issn 0169-5002, 3 p.Article

Traitement par radiofréquence des tumeurs pulmonaires = Radio-frequency tumor ablation in the thoraxBRILLET, P. Y; REMY-JARDIN, M.La Lettre du pneumologue. 2004, Vol 7, Num 2, pp 72-73, issn 1292-5977, 2 p.Article

Cancer bronchique = Lung cancerRevue de pneumologie clinique (Paris). 2004, Vol 60, Num 5, issn 0761-8417, 118 p., CAH2Conference Proceedings

IASLC Workshop Progress and Guidelines in the Management of Non-Small Cell Lung Cancer, September 8-12, 2002, Bruges, BelgiumVAN HOUTTE, Paul.Lung cancer. 2003, Vol 42, issn 0169-5002, 95 p., SUP1Conference Proceedings

The restaging issueVAN SCHIL, P.Lung cancer. 2003, Vol 42, pp S39-S45, issn 0169-5002, SUP1Conference Paper

How to combine cytotoxic and cytostatic agentsGRIDELLI, C.Lung cancer. 2002, Vol 38, pp S39-S40, issn 0169-5002, SUP1Conference Paper

Smoking behavior does not influence the natural course of pre-invasive lesions in bronchial mucosaPASIC, Arifa; VAN VLIET, Esther; BREUER, Roderick H et al.Lung cancer. 2004, Vol 45, Num 2, pp 153-154, issn 0169-5002, 2 p.Article

A phase I study of Topotecan, as a radiosensitizer, for thoracic malignanciesFOROUZANNIA, Afshin; SCHILLER, Joan; BERLIN, Jordan et al.Lung cancer. 2004, Vol 44, Num 1, pp 111-119, issn 0169-5002, 9 p.Article

Asbestos and mesothelioma in South AfricaABRATT, Raymond P; VOROBIOF, Daniel A; WHITE, Neil et al.Lung cancer. 2004, Vol 45, pp S3-S6, issn 0169-5002, SUP1Article

Glutathione pathway genes and lung cancer risk in young and old populationsYANG, P; BAMLET, W. R; EBBERT, J. O et al.Carcinogenesis (New York. Print). 2004, Vol 25, Num 10, pp 1935-1944, issn 0143-3334, 10 p.Article

Glycine-extended gastrin promotes the growth of lung cancerKOH, Theodore J; FIELD, John K; VARRO, Andrea et al.Cancer research (Baltimore). 2004, Vol 64, Num 1, pp 196-201, issn 0008-5472, 6 p.Article

Hormone replacement therapy and lung cancer risk: A case-control analysisSCHABATH, Matthew B; XIFENG WU; VASSILOPOULOU-SELLIN, Rena et al.Clinical cancer research. 2004, Vol 10, Num 1, pp 113-123, issn 1078-0432, 11 p., 1Article

Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesotheliomaVAN KLAVEREN, Rob J; AERTS, Joachim G. J. V; DE BRUIN, Hein et al.Lung cancer. 2004, Vol 43, Num 1, pp 63-69, issn 0169-5002, 7 p.Article

Increased expression of collagen XVIII and its prognostic value in nonsmall cell lung carcinomaHAO CHANG; IIZASA, Toshihiko; SHIBUYA, Kiyoshi et al.Cancer. 2004, Vol 100, Num 8, pp 1665-1672, issn 0008-543X, 8 p.Article

Role of enzymatically inactive procathepsin D in lung cancerVETVICKA, Vaclav; VETVICKOVA, Jana; BENES, Petr et al.Anticancer research. 2004, Vol 24, Num 5A, pp 2739-2743, issn 0250-7005, 5 p.Article

The epidemiology of asbestos-related diseasesNIKLINSKI, Jacek; NIKLINSKA, Wieslawa; CHYCZEWSKA, Elzbieta et al.Lung cancer. 2004, Vol 45, pp S7-S15, issn 0169-5002, SUP1Article

  • Page / 22